Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC
Gene · 2024
DOI: 10.1016/j.gene.2024.148403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene, 2024. Verfasst von Haolin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Apoptosis, Alcohol Oxidoreductases, Biomarkers, Tumor, DNA-Binding Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Anhui Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Recently, mounting evidence has highlighted the essential function of the C-terminal binding protein-1 divergent transcript (CTBP1-DT) in malignancies. However, its role in kidney renal clear cell carcinoma (KIRC) remains largely unknown. Our study aimed to identify the potential function of CTBP1-DT in KIRC. RT-qPCR, Kaplan-Meier survival analysis, Cox regression analysis, and nomogram analysis were utilized to determine the expression and effects of CTBP1-DT on survival. The subcellular localization of CTBP1-DT was determined using RNA fluorescence in situ hybridization (FISH). To investigate the functions of CTBP1-DT in regulating KIRC cell proliferation, migration, invasion, lipid synthesis, and apoptosis, we conducted CCK8, EdU, Transwell, and Oil Red O staining and cell apoptosis staining assays. The relationships between CTBP1-DT and the tumor microenvironment were investigated with multiple bioinformatics analysis algorithms and databases, including CYBERSORT, TIMER2, Spearman correlation test, tumor mutation burden (TMB), microsatellite instability (MSI), and immunophenoscore (IPS). According to our results, CTBP1-DT is a lncRNA located in the nucleus that is significantly upregulated in KIRC and is correlated with better clinical outcomes. Downregulating CTBP1-DT inhibited cell viability, migration, invasion, and lipid synthesis but triggered cell apoptosis. Additionally, we explored the potential effect of CTBP1-DT in regulating immune cell infiltration in KIRC and other malignancies. Furthermore, CTBP1-DT could be used to predict the effectiveness of targeted drugs and immune checkpoint inhibitors. In conclusion, we identified CTBP1-DT as a potential immunological biomarker and discovered the potential role of CTBP1-DT in regulating lipid synthesis and apoptosis resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: 2575241418@qq.com.
- Department of Pathogenic Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: 382917561@qq.com.
- Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China. Electronic address: xiaohaibing@ahmu.edu.cn.
Förderung
- Anhui Provincial Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Li, H., Fei, M., Zhang, Y., Xu, Q., Feng, R., Cao, J., Qu, Y., & Xiao, H. (2024). Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC. Gene. https://doi.org/10.1016/j.gene.2024.148403
Vancouver
Li H, Fei M, Zhang Y, Xu Q, Feng R, Cao J, et al. Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC. Gene. 2024. doi:10.1016/j.gene.2024.148403
BibTeX
@article{Li2024,
author = {Li, Haolin and Fei, Mintian and Zhang, Yi and Xu, Qili and Feng, Rui and Cao, Jing and Qu, Yan and Xiao, Haibing},
title = {Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC},
journal = {Gene},
year = {2024},
doi = {10.1016/j.gene.2024.148403}
}
EUVIMED